Page results
-
The National Hospital for Neurology and Neurosurgery (NHNN), Queen Square, is the UK's largest dedicated neurological and neurosurgical hospital. It provides comprehensive services for the diagnosis, treatment and care of all conditions that affect the brain, spinal cord, peripheral nervous system and muscles. Services include specialist neurosurgery, a brain tumour unit, the Hyper-acute Stroke Unit (HASU), an acute brain injury unit, the National Prion Clinic, a pioneering neuro-rehabilitation unit, the UK's first interventional MRI scanner, the largest specialised neurosurgical ITU and the only neuromedical ITU in the country. Together with its neighbour, the UCL Queen Square Institute of Neurology, it is a major international centre for research and training.
-
This page provides information about the WEB device and how it is used to treat cerebral (brain) aneurysms
-
A new surgical technique could remove the risk of urinary incontinence after surgery to remove the prostate for men with prostate cancer.
-
A UCLH rheumatology team is leading an exciting project to help understand the reasons for young people missing their hospital appointments and find ways to improve this.
-
This page provides information about the Palliative care and symptom control team
-
How UCLH uses clinical data in research.
-
Information on the insertion of an inflatable penile prosthesis
-
An immunotherapy drug given before surgery instead of chemotherapy meant that significantly more patients with a certain genetic profile were cancer free after surgery, according to clinical trial results presented by researchers at UCL and UCLH.
-
UCLH has recruited the first European participant to a trial looking at treating non-hospitalised Covid-19 patients with the drug remdesivir.
-
Participants reacted quicker and made fewer errors during menstruation, despite believing their performance would be worse, according to new research from UCL and the Institute of Sport, Exercise & Health (ISEH).
File results
-
FOI/2022/0070 - Viscosupplementation use and spend
-
FOI/2022/0071 - Sodium Hyaluronate eye drops
-
FOI/2022/0076 - Private patient third party involvement
-
FOI/2022/0080 - Bariatric equipment
-
FOI/2022/0083 - Estates and inrastructure failures
-
FOI/2022/0084 - CA9030 - UCLH-2609 VAT Support and Advice Services contract
-
FOI/2022/0091 - Pancreatic cancer
-
FOI/2022/0093 - Procurement of pre-printed stationery
-
FOI/2022/0094 - Emergency Covid funding - private FM contractors
-
FOI/2022/0097 - Incidence and treatment of breast cancer